The neuropeptide substance P and its receptor, the neurokinin 1 receptor (NK 1 R) have been proposed as possible targets for new antidepressant therapies. The present study investigated the effect of the NK 1 R antagonist L-760,735 and the tricyclic antidepressant clomipramine in the chronic psychosocial stress paradigm of adult male tree shrews. Animals were subjected to a 7-day period of psychosocial stress before the onset of daily oral administration of L-760,735 (10 mg kg −1 day −1 ) or clomipramine (50 mg kg −1 day −1 ). The psychosocial stress continued throughout the treatment period of 28 days. Brain metabolite concentrations were determined in vivo by proton magnetic resonance spectroscopy. Cell proliferation in the dentate gyrus and hippocampal volume were measured post mortem. Stress significantly decreased in vivo concentrations of N-acetyl-aspartate (−14%), creatine and phosphocreatine (−15%) and choline-containing compounds (−15%). The proliferation rate of the granule precursor cells in the dentate gyrus was reduced (−45%), and hippocampal volume was decreased (−14%). The stress-induced changes of brain metabolites, hippocampal volume and dentate cytogenesis rate were prevented by concomitant drug administration. Elevated myoinositol concentrations after both treatments hint to an astrocytic enhancement. These results suggest that-despite a different pharmacological profile-the NK 1 R antagonist L-760,735, a member of a novel class of antidepressant drugs, has comparable neurobiological efficacy to tricyclic antidepressants such as clomipramine. Molecular Psychiatry (2002) 7, 933-941.
Introduction
Functional and neuroanatomical studies suggest that substance P is an important stress neurotransmitter. The neuropeptide and its preferred tachykinin NK 1 R are expressed throughout stress-processing pathways of the brain including the periaqueductal gray, hypothalamus, amygdala and hippocampus. 1, 2 In rats, neurochemical studies have demonstrated an increase in septal and hippocampal substance P content following inescapable footshock. 3 Other studies reported a decrease in substance P content after immobilization stress. 4 Because these and other studies suggest that the activity of substance P-containing pathways is moduCorrespondence: E Fuchs, Division of Neurobiology, German Primate Center, Kellnerweg 4, 37077 Gö ttingen, Germany. E-mail: efuchsȰgwdg.de *Should be considered co-first authors by virtue of their contribution to this work. lated by stress, 5 the pharmacological blockade of NK 1 R might provide a mechanism to alleviate maladaptive stress-induced processes.
Depressive disorders are among the most common and life-threatening illnesses representing a significant public health problem, and despite extensive preclinical and clinical investigations, little is known about the underlying fundamental biology. 6 Limitations of current antidepressant medications such as the delay for a full therapeutic response, a substantial rate of nonresponders, and bothersome side effect profiles, merit the full exploration of all plausible agents with novel antidepressant mechanisms of action. One potential new treatment approach is the blockade of the substance Ppreferring NK 1 receptor. A recent clinical study reported promising results about the therapeutic efficacy of the NK 1 R antagonist MK-869 in depressed patients. 7 Using neuroanatomical, behavioral and electrophysiological techniques, preclinical studies also suggest that pharmacological blockade or deletion of the NK 1 R might be as effective as currently used anti-Molecular Psychiatry depressants to suppress psychological and behavioral stress responses. 8 For example, in guinea pigs, the selective NK 1 R antagonist L-760,735, a structural analogue of MK-869, attenuated neonatal vocalization. 9, 10 This effect was also reached by treating animals with antidepressant agents such as imipramine and fluoxetine, and also by anxiolytics like diazepam. 7 Though these findings are promising, the preclinical and clinical evaluation of NK 1 R antagonists as putative antidepressants requires more detailed investigations. 11, 12 In the brain, substance P is co-localized with one of the classical neurotransmitters, commonly with serotonin (5-HT). 13 This finding strengthened the view of involvement of substance P in affective disorders and sheds light on the putative role of NK 1 R antagonists via interaction with the cerebral serotonergic system. Recent animal studies suggest that the therapeutic effects of NK 1 R antagonists are at least in part mediated via changes in the 5-HT system. [14] [15] [16] However, one has to consider that NK 1 receptor antagonists such as MK-869 or its analogue L-760,735 are not interacting with 5HT re-uptake sites, serotonin, dopamine or noradrenaline receptors or with monoamine oxidase A or B. 8, 17 Obviously, these NK 1 antagonists work through a different pharmacological action than classical antidepressant drugs and thus may provide a new research tool with which to understand the neurobiological mechanism of action of antidepressant drugs.
The hippocampus is one of the brain structures that has been extensively studied with regard to the actions of stress, depression and antidepressant actions. 18, 19 Given the proposed clinical significance of stimulating neurogenesis in adulthood, especially in therapy of neuropsychiatric diseases involving the hippocampus, [20] [21] [22] it is important to investigate whether pharmacological blockade of NK 1 receptors would oppose stress-induced adverse effects in the hippocampal formation. So far, most of the studies investigating the effects of antidepressants on neurogenesis have used drugs acting through classic neurotransmitter systems, mainly the serotonergic system. Therapeutic interventions, such as treatment with serotonin reuptake inhibitors 23, 24 led to the hypothesis that impairments of neuronal viability and neuroplasticity are important causal factors for the pathobiology of mood disorders and suggest that antidepressant drugs act to overcome these deficiencies. [20] [21] [22] 25 To further test this hypothesis and to establish whether any plasticity changes can be related to pharmacological blockage of NK 1 receptors, the present study investigated the influence of the selective NK 1 R antagonist L-760,735 on cerebral processes. L-760,735 is a preclinical research tool and a structural analogue of MK-869. 7, 8 The central nervous effects of L-760,735 were compared to the tricyclic antidepressant clomipramine which is a well established antidepressant in clinical practice. 26 Based on the clinical evidence which links stressful life events with depressive episodes, 27 and taking advantage of the chronic psychosocial stress paradigm in male tree shrews, an established model for research on the pathophysiology of major depression, 28 we mimicked a situation of antidepressant medication in patients. The daily oral application of L-760,735 and clomipramine started after the stress-induced biobehavioral alterations had been established. The action of the drugs was followed across a clinically relevant time period of 4 weeks while the psychosocial stress continued during the whole treatment period. At the end of the experiment, we measured brain metabolite concentrations in vivo with localized proton magnetic resonance spectroscopy (MRS) and quantified cell proliferation in the dentate gyrus and the hippocampal volume post mortem. The primary aim was to determine whether selective blockade of NK 1 receptors produces a profile resembling that seen with an established antidepressant drug.
Materials and methods

Animals, experimental procedure and drug treatment
Experimentally naive adult male tree shrews (Tupaia belangeri, age in the range of 16 months) were obtained from the breeding colony at the German Primate Center (Gö ttingen, Germany). Animals were housed individually in air-conditioned facilities on a 12 h/12 h light/dark cycle with artificial illumination (lights on from 8:00 am to 8:00 pm) and with free access to food and water. 29 All treatments were performed during the day (activity period, lights on). Animal experiments were conducted in accordance with the European Communities Council Directive of November 24, 1986 (86/EEC) and were approved by the Government of Lower Saxony, Germany. The minimum number of animals required to obtain consistent data was employed.
Animals received the highly brain-penetrant NK 1 receptor antagonist L-760,735 (Merck, Sharp and Dohme Research Laboratories, Neuroscience Research Center, Harlow, UK) and clomipramine (Sigma) orally. This route of administration was chosen because oral application is the most common route of administration for antidepressants in psychiatric patients. Moreover, we aimed to minimize uncontrollable stress effects caused by daily injections.
Since the majority of available antagonists are designed to have high affinity for the human NK 1 receptor, 8 we conducted a pilot study to establish the dose of L-760,735 that blocks NK 1 receptors in the tree shrew brain. The methodology used is based on the ability of NK 1 receptor antagonists to block nicotineinduced vomiting in musk shrews. 30 In a coded study adult male tree shrews (n = 4) received either vehicle, L-760,735 (10 mg kg −1 ) or its low affinity analogue L-781,773 (10 mg kg −1 ) orally followed 30 min later by s.c. administration of (−)nicotine (4 mg kg −1 ; Sigma, Taufkirchen, Germany) and the number of emetic episodes occurring during the following 30 min was recorded. Each animal received each treatment in a cross-over design, with 10 days washout period between studies. Emetic episodes were abolished by L-760,735, whereas the low affinity analogue L-781,773 and vehicle were ineffective. These results show that this dose of L-760,735 penetrates into the tree shrew brain and effectively blocks central NK 1 receptors.
The experimental design was carried out according to our standard procedure. 25, 31 The experimental groups (Control; Stress; Stress + Clomipramine; Stress + L-760,735) and the experimental design are displayed in Figure 1 . The first experimental phase ('No Stress') lasted for 7 days, during which all animals remained undisturbed and body weight was recorded daily. The second phase of the experiment was a 7-day period, during which the animals of the Stress, Stress + Clomipramine, and the Stress + L-760,735 group were submitted to daily psychosocial conflict ('Stress'). For the induction of psychosocial conflict one naive male was introduced into the cage of a socially experienced male. After establishment of a clear dominant/subordinate relationship, the two animals were separated by a wire mesh barrier. As in earlier studies 31, 32 all of the naive animals became subordinate. The barrier was removed every day for approximately 1 h allowing physical contact between the two males only during this time. By this procedure, the subordinate animal was protected from repeated attacks, but it was constantly exposed to olfactory, visual and acoustic cues from the dominant. Under these conditions, subordinate animals displayed characteristic subordination behavior such as reduced locomotor activity and marking behavior. The third experimental phase consisted of the antidepressive drug treatments lasting for 28 days. During this time the stressed animals remained in the psychosocial conflict situation and were treated daily with the antidepressant drugs or vehicle, respectively. The animals of the Stress + L-760,735 group (10 mg kg −1 day −1 ) and of Stress + Clomipramine (50 mg kg −1 day −1 ) group received the compounds orally in the morning between 8:00 and 8:15 am. Previously, we reported that a daily dose of 50 mg kg −1 clomipramine is effective in reversing stress-induced endocrine and behavioral impairments in male tree shrews. 31 In all cases, the drug solutions were freshly prepared every second day and stored light protected and cool. Animals of the Stress ) or tap water (Stress). In total, the psychosocial stress exposure lasted 35 days. During experimental days 37-40, all animals underwent proton magnetic resonance spectroscopy (MRS) for in vivo measurements of brain metabolite concentrations. To evaluate dentate granule cell proliferation, 5-bromo-2Ј-deoxyuridine (BrdU; 100 mg kg
) was given i.p. in the morning of day 42, and the animals were killed 24 h later.
Molecular Psychiatry group were treated according to the same experimental schedule but received tap water only. The animals of the Control group were run in a separate experiment. They were individually housed and undisturbed in separate quarters elsewhere in the animal facility and received normal tap water. During all experimental phases body weight from all animals was recorded daily.
Localized proton magnetic resonance spectroscopy (MRS)
During experimental days 37-40, all animals underwent localized proton MRS in vivo to obtain the concentrations of major brain metabolites. Accessible neurochemicals include the neuroaxonal marker Nacetyl-aspartate (NAA), which putatively indicates neuronal viability and function, 33 creatine and phosphocreatine (Cr) as important energy metabolites and constituents of all cells, choline-containing compounds (Cho) representing formation and degradation products of cell membranes such as (glycero-) phosphocholine predominantly present in oligodendrocytes, 34 and myo-inositol (Ins) as a marker for astrocytes. 35 Detailed description of the measurements was given previously. 36 In brief, fully relaxed short echo-time proton MR spectra (STEAM, TR/TE/TM = 6000/20/10 ms, 64 averages) were acquired from a 0.245 ml (7 × 5 × 7 mm
3 ) volume-of-interest (VOI) at 2.35 T using a MRBR 4.7/400 mm magnet (Magnex Scientific, Abingdon, UK) driven by DBX electronics (Bruker, Karlsruhe, Germany). Radiofrequency excitation and signal reception were accomplished by a 14 cm Helmholtz coil and a 2 cm surface coil, respectively. Anesthetized animals (70:30 N 2 O:O 2 , 0.5-1.0% halothane) were measured in a prone position with their head firmly fixed between a plastic-made holder and the surface coil. The position of the VOI was carefully selected from multislice sagittal and coronal T1-weighted gradient-echo images (FLASH, TR/TE = 150/5 ms, 20°flip angle, 50 mm field-of-view, 256 × 256 data matrix, 1 mm sections) and centrally placed in the forebrain, including parasagittal neocortex, subjacent white matter and portions of subcortical forebrain structures (caudate-putamen, hippocampus, thalamus, ventricles). Metabolite quantification involved fully-automated and user-independent spectral evaluation by LCModel 37 and calibration with respect to the brain water concentration. 38 
Histological procedures
Bromodeoxyuridine injection and immunocytochemistry On the last experimental day (day 42) animals received a single i.p. injection of 5-bromo-2Ј-deoxyuridine (BrdU; 100 mg kg −1 ; Sigma) and were perfused 24 h later. This survival time allows for the completion of at least one cell cycle by cells in S phase at the time of BrdU injection. 39 In deep anesthesia the animals were perfused transcardially with 4% paraformaldehyde. Serial horizontal 50-m sections were collected with a freezing microtome throughout the dorsoventral extent of the left hippocampal formation. Every seventh section was slide-mounted and coded before processing for immunocytochemistry to ensure objectivity. According to the standard protocol 40 BrdU labeling requires the following pretreatment steps: DNA denaturation (0.01 M citric acid, pH 6.0, 95°C, 20 min), membrane permeabilization (0.1% trypsin, 10 min), and acidification (2 M HCl, 30 min). Primary antibody concentration was mouse anti-BrdU (DAKO, 1:100) and immuno-cytochemistry was completed by using the avidin-biotin/diaminobenzidine visualization method (Vector Laboratories) followed by counterstaining with hematoxylin.
Quantification of BrdU labeled cells
A modified unbiased stereology protocol was used that has been reported to successfully quantify BrdU labeling. 23, 25 Every seventh section (an average of 19) through the dorso-ventral extent of the left hippocampus was examined. All BrdU-labeled cells in the granule cell layer together with the subgranular zone, defined as a two-cell-body-wide zone along the border of the granule cell layer were counted regardless of size or shape. To enable counting of cell clusters, cells were examined under ×400 and ×1000 magnification, omitting cells in the outermost focal plane. The total number of BrdU-labeled cells was estimated by multiplying the number of cells counted in every 7th section by seven.
Measurement of hippocampal volume
To determine the volume of the entire hippocampus (hippocampus proper, dentate gyrus) and the granule cell layer, adjacent sections were analyzed by using the Neurolucida system (MicroBrightField, Colchester, VT, USA). Volumes were estimated on the basis of the Cavalieri principle, starting at a random position every 7th section (an average of 19). Briefly, the specific structures were outlined, the computed areas were then summed, and multiplied with the thickness of the sections and with the intersection distance.
Data analysis
Results are presented as the mean ± SEM. Treatment effects were assessed with a one-way ANOVA, followed by the Newman-Keuls test as post-hoc analysis for further examination of group differences.
Results
Body weight as indicator of stress
A decrease in body weight is an important and reliable indicator by which tree shrews can be classified as subordinates. 41 Animals from the Stress group displayed a significant reduction of body weight (P Ͻ 0.05) during the 5 weeks of psychosocial stress compared to the 'No stress' period ( Figure 2) . Treatment with L-760,735 or clomipramine ameliorated weight loss. In animals from the Control group body weight remained constant throughout the entire experimental procedure.
Effects of stress and antidepressants on brain metabolites
As shown in Figure 3 mean proton MR spectra of animals in the four groups exhibit marked alterations of the cerebral metabolite resonances for NAA, Cr, Cho and Ins in response to stress and treatment. The resulting concentrations are summarized in Table 1 . In Figure 2 Effects of chronic psychosocial stress and concomitant drug treatment on body weight. During the 5 weeks of psychosocial stress, body weight in the Stress (n = 5) group was significantly reduced (P Ͻ 0.05), whereas the body weight of the Control group (n = 5) remained almost constant. Drug treatment resulted in almost a complete recovery to the original body weight. Data are expressed as percentage of the values of the first experimental phase (No stress; 100% equals 220 ± 4 g) and are given as mean ± SEM. revealed significant difference between the groups (F (3,16) = 4,82; P Ͻ 0.05) and post hoc comparisons showed significant difference comparing the Control and the Stress group (q = 4,74; P Ͻ 0.05). Treatment of stressed animals with L-760,735 resulted in a significant increase in the number of BrdU-labeled cells in the dentate gyrus (q = 4,57; P Ͻ 0.05 vs Stress); a similar statistically significant increase was observed in the animals from the Stress + Clomipramine group (q = 3,02; P Ͻ 0.05 vs Stress). This suggests that chronic treatment with both antidepressants may overcome the stress-induced reduction of cell proliferation in the dentate gyrus.
Effects of stress and antidepressant treatment on hippocampal volume
Chronic exposure to psychosocial stress resulted in a significant decrease (−14%) of the hippocampal volume in subordinate tree shrews (Stress) compared to non-stressed Controls (Table 2) . One-way ANOVA revealed significant difference between groups (F (3,16) = 3,50; P Ͻ 0.05), and post hoc analysis showed significant difference comparing the Control and the Stress group (q = 4,49; P Ͻ 0.05). In stressed animals, treatment with the two antidepressants resulted in a tendency of volume normalization (Stress + L-760,735: +10%; Stress + Clomipramine: +7% increase in volume) yielding no differences compared to the Control group (Table 2) . Estimation of the volume of the granule cell layer revealed no differences in the volume after 5 weeks of chronic stress and concomitant antidepressant treatment in either group (ANOVA: F (3,16) = 0,27; P = 0.84; Table 2 ). This finding indicates that the decreased rate of cytogenesis in the gyrus dentatus of the Stress group is not accompanied by a volume loss of the granule cell layer.
Discussion
The present study confirms and extends earlier findings 25 that chronic psychosocial stress in male tree shrews significantly decreased in vivo concentrations of major cerebral metabolites, hippocampal volume and the proliferation rate of the granule precursor cells in the dentate gyrus. Here we demonstrated that blockade of NK 1 receptors with the selective antagonist L-760,735 prevented the stress-induced alterations and The volumes (mm 3 ) were determined post mortem and are given as mean ± SEM. Only the left hemisphere was analyzed. Control (n = 5), Stress (n = 5), Stress + Clomipramine (n = 5) and Stress + L-760,735 (n = 5). Significant differences vs Control: *P Ͻ 0.05. that the NK 1 receptor antagonist has a profile similar to that seen with the established antidepressant clomipramine. Although the functional implications of these findings have to be established, they reinforce recent hypotheses speculating that remodeling of neural circuits at cellular and molecular levels and stabilization of neural viability may lead to antidepressant effects. [20] [21] [22] 42 Stress-induced reductions of brain metabolites are prevented by antidepressants In line with our recent study on tianeptine, 25 chronically stressed animals revealed significantly decreased concentrations of NAA, Cr, and Cho. In comparison with the Stress group, stress-induced metabolic changes were significantly prevented by both antidepressants. In addition, both treatments led to elevated concentrations of Ins.
A detailed comparison with clinical studies of depressed subjects is hampered by the common use of metabolite ratios rather than metabolite concentrations in the respective literature. In fact, stress-induced reductions of NAA, Cho, and Cr would have escaped detection if the study would have been based on mere alterations of metabolite ratios. It is therefore not surprising that the use of metabolite ratios in clinical proton MRS studies of depressed subjects led to conflicting results. [43] [44] [45] [46] [47] Moreover, also the effects of drug administration would have been overseen, because the increased Ins concentrations lead to elevated Ins/Cr ratios which are not significantly different from those observed in the Stress group.
A decrease of the cerebral NAA level is commonly understood as a reduction of neuroaxonal cellular density and/or dysfunction. Interestingly, a recent clinical study reported an increase of the brain NAA concentration during mood stabilizer lithium treatment. 48 In coincidence with this finding, our results suggest that treatment with antidepressants may reestablish neuronal resilience. Because Cr is a major constituent of all cells, it is to be expected to find Cr alterations which parallel the NAA findings as long as the drug effects mainly reflect changes in cellular density. This is indeed observed, ie a stress-induced reduction of Cr which is prevented in treated animals.
Alterations of the Cho level have been discussed to result from changes of cytosolic choline compounds due to disturbances in the formation and degradation of cell membranes. Because Cho is highly concentrated in oligodendrocytes, 34 one may speculate about a respective reduction of cell number, size, and density as found in post mortem brains of depressed patients. 49 Interestingly, this finding in glial cells is not paralleled in astrocytes as evidenced by the observation of a normal concentration of the respective marker compound Ins after chronic stress. However, elevated Ins concentrations after both drug administrations suggest a glial involvement during the course of treatment, for example in terms of an astrocytosis, that accompanies stimulated growth of both neuronal and glial cells.
Stress-induced reduction in dentate cytogenesis is prevented by antidepressant treatment
Recent work implicates regulation of neurogenesis as a form of plasticity in the adult mammalian hippocampus. 50 One factor that potently suppresses adult neurogenesis is stress exposure. Decreased granule cell proliferation has been reported in subordinate tree shrews in response to acute and chronic psychosocial stress. 40, 25 In the current experiments, animals were stressed for 7 days before the antidepressant drug treatments started. Thus, it is very likely that the cell proliferation rate was initially suppressed due to stress and reversed across the antidepressant application.
Regulation of neurogenesis is a complex process and several hypotheses can be considered regarding the mechanisms by which new neurons are produced in the adult dentate gyrus. Among others, the neurotransmitter serotonin (5-HT) is thought to be involved because therapeutic interventions, such as treatment with the selective serotonin reuptake inhibitor fluoxetine, stimulated neurogenesis. 23, 24 In line with these results one can explain the beneficial effect of clomipramine on granule cell proliferation since this tricyclic antidepressant is a potent and preferential inhibitor of 5-HT reuptake. 26 Moreover, there is a growing body of evidence suggesting that mood stabilizers and antidepressants exert neurotrophic effects. Recent reports indicated that lithium, the monoamino oxidase inhibitor tranylcypromine, the modified tricyclic tianeptine, and the norepinephrine-selective reuptake inhibitor reboxetine positively affected neurogenesis. 51, 23, 25 Substance P and NK 1 receptors are intimately associated with ascending serotonergic and noradrenergic projections to the forebrain including the hippocampus.
1,2 The close anatomical relationship between substance P, NK 1 receptors and classical transmitter systems such as the 5-HT system raises the question whether NK 1 blockade alters 5-HT function. In rats treated with the NK 1 antagonist GR205171 the efflux of serotonin in the hippocampus was not increased 52 and there was no alteration in basal serotonin efflux in NK 1 receptor knock-out mice. 16 These findings are in contrast to increased serotonin efflux in terminal regions of the 5-HT system after administration of selective serotonin reuptake inhibitors. 53 The hippocampal formation is usually cited as an example of a brain region where a mismatch between Molecular Psychiatry the substance P innervation and its receptors occurs. The dentate gyrus is apparently not heavily innervated by substance P-containing fibers but a strong immunoreactivity for NK1 receptors is described for this part of the hippocampal formation. 1, 2 Whether blockade of these receptors by L-760,735 and/or interaction with the serotonergic or other neurotransmitter systems are related to the observed neurotrophic effects of the receptor antagonist should warrant further investigations.
Stress-induced hippocampal volume loss is prevented by antidepressant treatment
Recent imaging studies in humans revealed that the hippocampus undergoes selective volume reduction in several stress-related neuropsychiatric illnesses such as recurrent depressive illness or post-traumatic stress disorder. [54] [55] [56] [57] Besides reduced neurogenesis, the hippocampal formation has also been shown to undergo another morphological change in response to stress, namely the retraction of apical dendrites of CA3 pyramidal neurons. 58 Based on these findings in animals, the clinically observed hippocampal volume loss is-at least partially-explained by dendritic retraction and reduced cell proliferation. 19, 59 Among the mechanistic explanations for the remodeling, one may speculate that the reversibility is due to alterations in the dendritic, axonal and synaptic components as well in the glia cells of the hippocampal neural network. 60 To definitively determine the cellular bases of these observations and which cellular components are specifically affected, detailed immunohistochemical and molecular studies are needed.
Conclusions
Four weeks of social conflict induced in subordinate tree shrews a significant decrease in major brain metabolites, a reduction in the proliferation rate of the granule precursor cells in the dentate gyrus and a mild hippocampal volume loss which can be prevented by concomitant treatment with the antidepressant tianeptine. 25 This latter finding, together with the results of the present study, is intriguing because it demonstrates a similar neurobiological profile for three different antidepressants L-760,735, clomipramine, and tianeptine. Moreover, these data extend the experimental evidence for recent concepts of pharmacological modification of neuronal viability and neuronal remodeling in the treatment of mood disorders. Although these concepts are still in their infancy, they have increasingly attracted research efforts which may result in new treatment strategies of neural resilience responsible for the etiopathophysiology of psychiatric disorders, such as major depression.
